Fourier Intelligence has filed confidential IPO documents with the Hong Kong Stock Exchange, according to regulatory disclosures released this week. The Shanghai-based robotics firm has not disclosed a target raise amount or timeline for the public debut, but three people familiar with the preparation told RoboticsIntl.com that underwriters are modeling a valuation range between $1.8 billion and $2.4 billion depending on market conditions at launch. That would make Fourier the first dedicated humanoid robot company to complete a major public offering, arriving ahead of better-funded U.S. competitors like Figure AI and Apptronik that have raised hundreds of millions in private capital but shown no indication of going public in the near term.
Fourier has shipped approximately 200 units of its GR-1 humanoid platform since the robot entered commercial availability in mid-2024, primarily to research institutions and pilot deployment partners in logistics and light manufacturing. The 5-foot-5-inch, 121-pound machine walks at 3.1 miles per hour, features 40 degrees of freedom, and carries a per-unit cost estimated at $150,000 based on early customer contracts reviewed by this publication. Revenue from robot sales remains modest—likely in the low tens of millions annually based on unit economics—but Fourier has positioned the IPO as growth capital rather than an exit for early investors. Proceeds will fund a new 120,000-square-foot assembly facility in Suzhou capable of producing 5,000 humanoid units per year by late 2027, according to the preliminary prospectus. The company currently assembles robots at a smaller Shanghai facility with estimated annual capacity of 800 units.
The public filing arrives as Chinese robotics manufacturers accelerate efforts to compete with Western humanoid developers that have attracted significant venture backing and partnership announcements from major technology firms. Figure AI closed a $675 million Series B in February 2024 at a $2.6 billion valuation with participation from Microsoft, NVIDIA, and Amazon, while Boston Dynamics' electric Atlas platform and Tesla's Optimus project have generated headlines despite limited commercial availability. Fourier has taken a different path, focusing on rehabilitation exoskeletons and medical robotics before pivoting to humanoids, which gives it an established revenue base—roughly $45 million in 2025 from its legacy products—that pure-play humanoid startups lack. The company's prospectus lists Sequoia Capital China and Qiming Venture Partners as major shareholders, alongside Shanghai municipal investment vehicles that provided early-stage funding.
Industry observers see the IPO as a test case for public market appetite for humanoid robotics investments, which have so far remained the domain of venture firms willing to absorb years of cash burn before meaningful revenue materializes. Several robotics executives and institutional investors interviewed for this article expressed skepticism about near-term profitability given the capital intensity of humanoid production and the narrow customer base for six-figure robots with limited task versatility. One Hong Kong-based fund manager who declined to be named said his team would focus on Fourier's customer concentration and repeat purchase rates as key indicators of whether humanoid demand represents a sustainable market or remains confined to pilot projects and research deployments. The prospectus will need to address unit economics in detail, including gross margins on robot sales, software licensing revenue if any, and the cost structure of scaled production compared to current small-batch assembly. Competitors like Unitree, also based in China, have undercut Fourier on price with the $16,000 G1 model, though that machine targets a different segment with reduced capabilities and a focus on research and hobbyist users rather than industrial deployment.
What to Watch: Fourier's prospectus will provide the robotics industry's first detailed public look at humanoid unit economics, including margins, production costs, and customer acquisition expenses. Watch for feedback from institutional investors during the roadshow, particularly questions about competitive positioning against better-funded U.S. rivals and lower-cost Chinese manufacturers. The company is expected to name underwriters and a preliminary pricing range within 60 days. Also track whether Figure AI or other private humanoid developers respond with new fundraising announcements or partnership deals that could reset valuation expectations before Fourier prices its offering.
